Navigation Links
Amicus Therapeutics Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease
Date:12/8/2010

ty of brain GCase, prevented accumulation of α-synuclein in the brain, and improved motor function as assessed in various behavioral tests.  Through a significant medicinal chemistry effort, Amicus has identified new pharmacological chaperones that improve significantly on the properties of AT2101 and that have better potential for clinical development. 

About Parkinson's Disease

Parkinson's disease is a progressive neurological disease that affects over 1 million people in the US.  It is most commonly associated with changes in motor function such as tremor, rigidity, slowness of movement, and postural instability, but also affects cognition and peripheral functions.  The prevalence of Parkinson's increases above 60 years of age and thus the patient population is expected to grow in the next several decades.

About the Michael J. Fox Foundation for Parkinson's Research

Founded in 2000, MJFF is dedicated to finding a cure for Parkinson's disease through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today. The Foundation has funded more than $221 million in research to date. For more information, please visit www.michaeljfox.org.

About Amicus Therapeutics

Amicus Therapeutics is developing orally administered, small molecule drugs called pharmacological chaperones, a novel, first-in-class approach to treating a broad range of diseases including lysosomal storage disorders and neurodegenerative diseases.  Amicus' lead program is in Phase 3 for Fabry disease. For more information about Amicus please visit www.amicustherapeutics.com.

Forward-Looking Statements

This press release contains, and the accompanying conference call will contain, "forward-looking state
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Amicus Therapeutics Announces Third Quarter 2010 Financial Results
2. GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
3. Amicus Therapeutics to Host Conference Call and Webcast to Discuss Exclusive Worldwide Agreement with GSK to Develop and Commercialize Amigal™ for Fabry Disease
4. Amicus Therapeutics to Host Its Second Quarter 2010 Financial Results Conference Call and Webcast on August 5, 2010
5. Amicus CEO Represents BIO on Rare Diseases at U.S. Senate Committee on Health, Education, Labor and Pensions Bipartisan Hearing
6. Alzheimers Drug Discovery Foundation Funds Amicus Therapeutics To Advance Pharmacological Chaperone Technology
7. Fenwal Receives FDA Clearance for Amicus(R) Separator With Wireless Connectivity
8. Amicus Therapeutics to Host its First Quarter 2010 Financial Results Conference Call and Webcast on May 6, 2010
9. FDA Clears the Fenwal Amicus(R) Separator System for Collecting Platelets in New Additive Solution
10. Amicus Therapeutics Announces Closing of $18.5 Million Registered Direct Offering of Common Stock
11. Amicus Therapeutics Announces $18.5 Million Registered Direct Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 More than a third ... quarter of those with private insurance, filled a prescription for ... a report in this week,s Morbidity and Mortality Weekly Report ... care providers to treat moderate to severe pain.  They are ...
(Date:1/23/2015)... MERIDIAN, Idaho , Jan. 23, 2015  Now available ... Patent No. 7,849,611) support that prevents ankle sprains by ... a brace, it fits securely around the outside of ... ankle mobility & comfort while still offering protection against ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
... Jan. 12, 2011 InstaCare Corp. (OTC Bulletin ... non-prescription diagnostics, home testing products for the chronically ... patient diabetes programs, and a leading developer of ... announced that the company,s Board of Directors has ...
... Intrasphere Technologies ( http://www.intrasphere.com ), a drug safety ... to Life Sciences organizations, today announced that it ... and deliver global partner-focused training for the Oracle® ... program. Enablement 2.0 is Oracle,s commitment to the ...
Cached Medicine Technology:InstaCare Corp. Announces 2011 Genstrip Guidance Report Penned by William Walling, CFA 2Intrasphere Technologies to Help Develop and Deliver Global Partner Training for the Oracle(R) Argus Safety Suite Through Oracle PartnerNetwork 2
(Date:1/22/2015)... Liberty University has received accreditation for its resident Clinical ... for Accreditation of Counseling & Related Educational Programs (CACREP). ... & Family Studies , is under the leadership of Dr. ... Behavioral Sciences. Prior to the formation of the new school, ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located ... the number one best large hotel for families in the ... their annual Travelers’ Choice Awards. , TripAdvisor represents the ... home to millions of unbiased and honest traveler reviews. The ...
(Date:1/22/2015)... VogueQueen is a seasoned and trusted leader who consistently ... thrilled to have it lead the wedding dress industry into ... prom dresses for the global market. , “The CEO of ... he focuses on continuing the goal of operational excellence and ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Blue Cross and ... Minnesotans who exemplify what it means to “Live Fearless.” ... for people to share their stories about how they or ... simply inspired others by living in the moment. By telling ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
Breaking Medicine News(10 mins):Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3
... Even though Americans pick up their,toothbrushes for a ... cleaning of their own. Celebrity Dentist Dr. Bill Dorfman ... survey conducted by the,Philips Sonicare brand shows dirty brushes ... this report from Philips (NYSE: PHG ) at:, ...
... Operate in Countries Around the World; First Centers to Open ... in Japan, U.S., France and China, Kenneth P. Moritsugu, M.D., Former Acting ... ... (NYSE: JNJ ) today announced the establishment of the Johnson &,Johnson Diabetes Institute ...
... how HIV evolves over the course of a persons lifetime ... full-blown AIDS. The findings could pave the way for new ... process, before it takes a lethal turn, researchers say. , ... from the beginning of the infection until the end, said ...
... seventh,consecutive year West Coast Bank will partner with other ... of Doernbecher Auction, which,has raised over $2.5 million for ... will be held at Portland Art Museum, October 20, ... Vice President of Commercial Banking Xandra,McKeown serves as President ...
... 16 D.I.S.C. (Diagnostic and,Interventional Spinal and Sports Care) ... Center" of the N.H.L.,s Los,Angeles Kings hockey team. The ... sports marketing arena in a very significant,way. "This ... for us and we,are thrilled to be their Official ...
... Medical Services,International Inc (Pink Sheets: MSITF) wishes to announce that ... retail sales. The kits,will be available on an individual basis ... the Company will sell up to,50,000 Hepatitis test kits in ... and don,t know they have it is estimated by WHO ...
Cached Medicine News:Health News:Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals 2Health News:Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals 3Health News:Johnson & Johnson Launches Global Diabetes Institute to Provide State-of-The- Art Education, Training to Health Professionals 4Health News:UF researchers track genetic journey of HIV from birth to death 2Health News:UF researchers track genetic journey of HIV from birth to death 3Health News:West Coast Bank Will Sponsor the Heart of Doernbecher Auction at the Portland Art Museum, October 20, 2007 2Health News:D.I.S.C. Scores First Sponsorship Deal as Official Medical Center of the Los Angeles Kings 2
ELISA kit for the quantitative determination of autoantibodies to IA-2 in serum...
Inquire...
Bench Top Class I Containment Cabinet Personnel Protection...
Inquire...
Medicine Products: